Literature DB >> 23857445

Chronic pain management in pregnancy and lactation.

F Coluzzi1, H Valensise, M Sacco, M Allegri.   

Abstract

During pregnancy most of women will experience some kind of pain, either as a result of a pre-existing condition (low back pain, headache, fibromyalgia, and rheumatoid arthritis) or as a direct consequence of pregnancy (weight gain, postural changes, pelvic floor dysfunction, hormonal factors). However, chronic pain management during pregnancy and lactation remains a challenge for clinicians and pregnant women are at risk of undertreatment for painful conditions, because of fear about use of drugs during pregnancy. Few analgesic drugs have been demonstrated to be absolutely contraindicated during pregnancy and breastfeeding, but studies in pregnant women are not available for most of pain medications. The aim of this paper is to review the safety profile in pregnancy or lactation of the commonly prescribed pain medications and non-pharmacological treatments. In addition to the conventional classifications from the Food and Drug Administration and the American Academy of Paediatrics, authors analyzed the currently available clinical data from literature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23857445

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  12 in total

1.  Balance in opioid prescription during pregnancy.

Authors:  Pamela Flood; Srinivasa N Raja
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

2.  Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011.

Authors:  Julia D Interrante; Elizabeth C Ailes; Jennifer N Lind; Marlene Anderka; Marcia L Feldkamp; Martha M Werler; Lockwood G Taylor; James Trinidad; Suzanne M Gilboa; Cheryl S Broussard
Journal:  Ann Epidemiol       Date:  2017-09-20       Impact factor: 3.797

Review 3.  Microphysiological modeling of the reproductive tract: a fertile endeavor.

Authors:  Sharon L Eddie; J Julie Kim; Teresa K Woodruff; Joanna E Burdette
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-15

4.  Effectiveness of manual lymphatic drainage vs. perineal massage in secundigravida women with gestational oedema: A randomised clinical trial.

Authors:  Mónica de la Cueva-Reguera; David Rodríguez-Sanz; César Calvo-Lobo; Silvia Fernández-Martínez; Beatriz Martínez-Pascual; Yolanda Robledo-Do-Nascimento; María Blanco-Morales; Carlos Romero-Morales
Journal:  Int Wound J       Date:  2020-06-13       Impact factor: 3.315

5.  Neuropathic Pain due to Neurofibromatosis Treated With Transcutaneous Electrical Nerve Stimulation in a Pregnant Patient: A Case Report.

Authors:  Victor Caño Silva; Ancor Serrano Afonso
Journal:  A A Pract       Date:  2019-11-01

6.  Psychological distress and self-rated health status in reproductive aged women with pain: findings from a national, cross-sectional survey.

Authors:  April M Miller; Fiona Judd; Peter A Dargaville; Amanda L Neil
Journal:  BMC Womens Health       Date:  2019-05-07       Impact factor: 2.809

7.  The effect of fibromyalgia syndrome to gravidity, parity and duration of breastfeeding; A prospective study from Turkey.

Authors:  Koca Tuba Tulay; Tanrikut Emrullah; Arslan Aydin; Ozdemir Filiz Ciledag
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

Review 8.  Headache and pregnancy: a systematic review.

Authors:  A Negro; Z Delaruelle; T A Ivanova; S Khan; R Ornello; B Raffaelli; A Terrin; U Reuter; D D Mitsikostas
Journal:  J Headache Pain       Date:  2017-10-19       Impact factor: 7.277

Review 9.  Chronic pain during pregnancy: a review of the literature.

Authors:  Shona L Ray-Griffith; Michael P Wendel; Zachary N Stowe; Everett F Magann
Journal:  Int J Womens Health       Date:  2018-04-09

Review 10.  Will Widespread Synthetic Opioid Consumption Induce Epigenetic Consequences in Future Generations?

Authors:  Federica Gilardi; Marc Augsburger; Aurelien Thomas
Journal:  Front Pharmacol       Date:  2018-07-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.